Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.

scientific article

Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IMBIO.2010.09.008
P932PMC publication ID3049830
P698PubMed publication ID20956025
P5875ResearchGate publication ID47459026

P50authorJessica M S JutzyQ84757328
Nathan R. WallQ38324556
P2093author name stringWilliam Langridge
Oludare Odumosu
Kimberly Payne
Ineavely Baez
P2860cites workAltered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetesQ80736018
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAQ81487908
Expression of chemokine-like factor 1 is upregulated during T lymphocyte activationQ82754186
A Toll-like receptor recognizes bacterial DNAQ24290668
Toll-like receptor signallingQ24570126
Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutantsQ27732558
Crystal structure of a new heat-labile enterotoxin, LT-IIbQ27733378
Toll-like receptorsQ27860671
Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortionsQ28282106
Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetesQ28299458
Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6Q28646148
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytesQ29619621
Reciprocal control of T helper cell and dendritic cell differentiationQ74452751
Toll-like receptors control activation of adaptive immune responsesQ74486847
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cellsQ77291206
The Th1/Th2 paradigm and allergic disordersQ77591388
Th1 and Th2 cellsQ77922246
Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) miceQ78402068
Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitusQ80506814
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetesQ80587031
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic miceQ30498716
[Detection of IFN-gamma level in single CD8+ T cell].Q33210532
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at largeQ33342232
Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxinsQ33716162
Developmental control of CD8 T cell-avidity maturation in autoimmune diabetesQ33840423
The NOD mouse model of type 1 diabetes: as good as it gets?Q33865111
Differentiation of T regulatory cells by immature dendritic cellsQ34157114
Type I diabetes mellitus. A chronic autoimmune diseaseQ34181699
Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDELQ34289590
Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.Q34324135
Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patchesQ34521786
Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.Q34674471
Recent advances in mucosal vaccines and adjuvantsQ34786990
Distinct dendritic cell subsets differentially regulate the class of immune response in vivoQ34950113
Recognition of pathogen-associated molecular patterns by TLR familyQ35044748
Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly systemQ35106484
Initial studies of the structural signal for extracellular transport of cholera toxin and other proteins recognized by Vibrio cholerae.Q35445424
Dendritic-cell control of pathogen-driven T-cell polarizationQ35597117
Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agentQ35619878
Human CD(4+)CD(25+) regulatory T cells and infectious toleranceQ35630656
Dendritic cell immunotherapy: mapping the way.Q35762464
Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological toleranceQ35878983
New insights into the molecular mechanism of interleukin-10-mediated immunosuppressionQ35937678
A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetesQ36140954
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes MellitusQ36176985
Autoimmune destruction of pancreatic beta cells.Q36310464
The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic miceQ36367836
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylaseQ36370946
B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetesQ36437651
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory stateQ36459935
Targeting cytokines of the interleukin-12 family in autoimmunityQ36486132
Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators.Q36595292
TLR signaling pathways: opportunities for activation and blockade in pursuit of therapyQ36651901
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonistsQ36811131
What predicts mucosal inflammation in Crohn's disease patients?Q36896566
Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigensQ36968782
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivoQ37084615
IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrowQ37137338
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunitQ37494112
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulinQ37622936
Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cellsQ39522002
Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell linesQ39788361
Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturationQ39971245
Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigensQ40382880
The role of IL-12 in the induction of organ-specific autoimmune diseasesQ40404319
Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity.Q40467105
Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expressionQ40493664
Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkwormQ42035404
Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear diseaseQ43683297
Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activationQ44015062
B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic miceQ44262351
Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitisQ45889466
A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetesQ45889680
Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coliQ46052151
Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapyQ46155756
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's diseaseQ47346480
Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assayQ47594873
Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells.Q47682161
Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro.Q51035411
Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice.Q53928842
[Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies].Q54490397
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitopeQ59060541
Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF- B Activation in Tumor-Associated MacrophagesQ59510838
Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell ActivationQ59632296
Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentQ70311233
Insulin-dependent diabetes mellitusQ71046915
Immunization With the Larger Isoform of Mouse Glutamic Acid Decarboxylase (GAD67) Prevents Autoimmune Diabetes in NOD MiceQ71656099
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4Q71828924
The pathogenesis of insulin-dependent diabetes mellitusQ72827807
Effects of oral administration of type II collagen on rheumatoid arthritisQ72936919
Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expressionQ73010751
Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunitQ73022255
Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunitQ73066956
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunityQ73691187
Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell toleranceQ73701505
Induction of tolerance by IL-10-treated dendritic cellsQ73873437
The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouseQ74371030
Efficacy of a food plant-based oral cholera toxin B subunit vaccineQ74401546
P433issue4
P921main subjectcholeraQ12090
dendritic cellQ506253
P304page(s)447-456
P577publication date2010-09-24
P1433published inImmunobiologyQ15754985
P1476titleSuppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit
P478volume216